BioXcel Therapeutics, Inc. (BTAI)
1.13
-0.01
(-0.88%)
USD |
NASDAQ |
May 22, 16:00
1.14
+0.01
(+0.88%)
After-Hours: 20:00
BioXcel Therapeutics EPS Diluted (Quarterly) : -0.5384 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Verastem, Inc. | -0.3723 |
| Quince Therapeutics, Inc. | 3.908 |
| ACADIA Pharmaceuticals, Inc. | 0.0211 |
| Alnylam Pharmaceuticals, Inc. | 1.508 |
| Amgen, Inc. | 3.344 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -12.69M |
| Revenue (Quarterly) | 0.206M |
| Total Expenses (Quarterly) | 12.90M |
| Enterprise Value | 118.00M |
| Gross Profit Margin (Quarterly) | -65.53% |
| Profit Margin (Quarterly) | -6.16K% |
| Earnings Yield | -547.8% |
| Normalized Earnings Yield | -501.47 |